Kovai Medical Centre and Hospital Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
4062.00 +27.80 (0.69%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
4034.2
Today’s High
4074
52 Week Low
1946.38
52 Week High
4271.95
2576.65 0 0%
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2505.6
Today’s High
2637.7
52 Week Low
1472.12
52 Week High
2844.43
Key Metrics
- Market Cap (In Cr) 4401.09
- Beta 0.75
- Div. Yield (%) 0.12
- P/B 6.12
- TTM P/E 21.45
- Peg Ratio 0.54
- Sector P/E 28.96
- D/E -
- Open Price 4054
- Prev Close 4034.2
Kovai Medical Centre and Hospital Analysis
Price Analysis
-
1 Week6%
-
3 Months5.7%
-
6 Month14.57%
-
YTD29.77%
-
1 Year98.52%
Risk Meter
- 34% Low risk
- 34% Moderate risk
- 34% Balanced Risk
- 34% High risk
- 34% Extreme risk
Kovai Medical Centre and Hospital Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2023
- Total Revenue
- 1019.75
- Selling/ General/ Admin Expenses Total
- 443.82
- Depreciation/ Amortization
- 89.12
- Other Operating Expenses Total
- 5.95
- Total Operating Expense
- 839.3
- Operating Income
- 180.45
- Net Income Before Taxes
- 155.22
- Net Income
- 115.77
- Diluted Normalized EPS
- 106.5
- Period
- 2023
- Total Assets
- 1442.05
- Total Liabilities
- 723.01
- Total Equity
- 719.04
- Tangible Book Valueper Share Common Eq
- 655.66
- Period
- 2023
- Cashfrom Operating Activities
- 32.27
- Cashfrom Investing Activities
- -126.86
- Cashfrom Financing Activities
- -85.7
- Net Changein Cash
- -180.29
- Period
- 2022
- Total Revenue
- 906
- Selling/ General/ Admin Expenses Total
- 364.02
- Depreciation/ Amortization
- 85.43
- Other Operating Expenses Total
- 12.12
- Total Operating Expense
- 732.96
- Operating Income
- 173.03
- Net Income Before Taxes
- 140.68
- Net Income
- 104.26
- Diluted Normalized EPS
- 95.92
- Period
- 2022
- Total Assets
- 1342.66
- Total Liabilities
- 733.35
- Total Equity
- 609.31
- Tangible Book Valueper Share Common Eq
- 554.53
- Period
- 2022
- Cashfrom Operating Activities
- 69.73
- Cashfrom Investing Activities
- -99.1
- Cashfrom Financing Activities
- -119.77
- Net Changein Cash
- -149.13
- Period
- 2021
- Total Revenue
- 690.36
- Selling/ General/ Admin Expenses Total
- 284.42
- Depreciation/ Amortization
- 68.03
- Other Operating Expenses Total
- 6.47
- Total Operating Expense
- 565.08
- Operating Income
- 125.28
- Net Income Before Taxes
- 105.74
- Net Income
- 77.69
- Diluted Normalized EPS
- 70.89
- Period
- 2021
- Total Assets
- 1280.81
- Total Liabilities
- 770.81
- Total Equity
- 510
- Tangible Book Valueper Share Common Eq
- 463.77
- Period
- 2021
- Cashfrom Operating Activities
- 38.18
- Cashfrom Investing Activities
- -180.48
- Cashfrom Financing Activities
- 38.03
- Net Changein Cash
- -104.27
- Period
- 2020
- Total Revenue
- 711.73
- Selling/ General/ Admin Expenses Total
- 316.98
- Depreciation/ Amortization
- 52.12
- Other Operating Expenses Total
- 6.24
- Total Operating Expense
- 594.49
- Operating Income
- 117.24
- Net Income Before Taxes
- 111.91
- Net Income
- 94.59
- Diluted Normalized EPS
- 72.3
- Period
- 2020
- Total Assets
- 1107.21
- Total Liabilities
- 676.17
- Total Equity
- 431.04
- Tangible Book Valueper Share Common Eq
- 393.13
- Period
- 2020
- Cashfrom Operating Activities
- 85.23
- Cashfrom Investing Activities
- -267.82
- Cashfrom Financing Activities
- 112.78
- Net Changein Cash
- -69.81
- Period
- 2019
- Total Revenue
- 628.39
- Selling/ General/ Admin Expenses Total
- 290.55
- Depreciation/ Amortization
- 35.53
- Other Operating Expenses Total
- 5.99
- Total Operating Expense
- 531.61
- Operating Income
- 96.78
- Net Income Before Taxes
- 92.84
- Net Income
- 60.14
- Diluted Normalized EPS
- 54.95
- Period
- 2019
- Total Assets
- 849.62
- Total Liabilities
- 506.37
- Total Equity
- 343.24
- Tangible Book Valueper Share Common Eq
- 312.89
- Period
- 2019
- Cashfrom Operating Activities
- 44.51
- Cashfrom Investing Activities
- -270.26
- Cashfrom Financing Activities
- 160.07
- Net Changein Cash
- -65.68
- Period
- 2018
- Total Revenue
- 588.33
- Selling/ General/ Admin Expenses Total
- 261.68
- Depreciation/ Amortization
- 34.33
- Other Operating Expenses Total
- 8.07
- Total Operating Expense
- 493.17
- Operating Income
- 95.16
- Net Income Before Taxes
- 89.44
- Net Income
- 57.98
- Diluted Normalized EPS
- 52.94
- Period
- 2018
- Total Assets
- 604.88
- Total Liabilities
- 317.57
- Total Equity
- 287.31
- Tangible Book Valueper Share Common Eq
- 261.82
- Period
- 2018
- Cashfrom Operating Activities
- 18.22
- Cashfrom Investing Activities
- -122.94
- Cashfrom Financing Activities
- 59.97
- Net Changein Cash
- -44.75
- Period
- 2023-12-31
- Total Revenue
- 321.11
- Selling/ General/ Admin Expenses Total
- 100.95
- Depreciation/ Amortization
- 23.34
- Other Operating Expenses Total
- 39.94
- Total Operating Expense
- 248.12
- Operating Income
- 72.99
- Net Income Before Taxes
- 70.51
- Net Income
- 53.1
- Diluted Normalized EPS
- 48.52
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 302.73
- Selling/ General/ Admin Expenses Total
- 97.74
- Depreciation/ Amortization
- 22.96
- Other Operating Expenses Total
- 39.47
- Total Operating Expense
- 240.43
- Operating Income
- 62.3
- Net Income Before Taxes
- 58.39
- Net Income
- 43.41
- Diluted Normalized EPS
- 39.67
- Period
- 2023-09-30
- Total Assets
- 1400.56
- Total Liabilities
- 619.46
- Total Equity
- 781.1
- Tangible Book Valueper Share Common Eq
- 712.86
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 0.88
- Cashfrom Investing Activities
- -60.61
- Cashfrom Financing Activities
- -147.65
- Net Changein Cash
- -207.37
- Period
- 2023-06-30
- Total Revenue
- 274.61
- Selling/ General/ Admin Expenses Total
- 94.24
- Depreciation/ Amortization
- 22.31
- Other Operating Expenses Total
- 36.85
- Total Operating Expense
- 228.5
- Operating Income
- 46.11
- Net Income Before Taxes
- 41.75
- Net Income
- 31.05
- Diluted Normalized EPS
- 28.38
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 266.99
- Selling/ General/ Admin Expenses Total
- 50.29
- Depreciation/ Amortization
- 21.68
- Other Operating Expenses Total
- 74.9
- Total Operating Expense
- 221.58
- Operating Income
- 45.4
- Net Income Before Taxes
- 40.67
- Net Income
- 30.56
- Diluted Normalized EPS
- 27.93
- Period
- 2023-03-31
- Total Assets
- 1442.05
- Total Liabilities
- 723.01
- Total Equity
- 719.04
- Tangible Book Valueper Share Common Eq
- 655.66
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 32.27
- Cashfrom Investing Activities
- -126.86
- Cashfrom Financing Activities
- -85.7
- Net Changein Cash
- -180.29
- Period
- 2022-12-31
- Total Revenue
- 264.43
- Selling/ General/ Admin Expenses Total
- 46.29
- Depreciation/ Amortization
- 22.31
- Other Operating Expenses Total
- 73.92
- Total Operating Expense
- 215.28
- Operating Income
- 49.15
- Net Income Before Taxes
- 42.74
- Net Income
- 31.14
- Diluted Normalized EPS
- 28.45
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Kovai Medical Centre and Hospital Technical
Moving Average
SMA
- 5 Day3981.71
- 10 Day3934.64
- 20 Day4028.29
- 50 Day3898.35
- 100 Day3669.5
- 300 Day3225
Kovai Medical Centre and Hospital Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Vijaya Diagnostic Centre
- 800
- 24.75
- 3.19
- 838
- 367.05
- 8187.66
- Healthcare Global Enterprises
- 359.15
- -5.15
- -1.41
- 401
- 276.45
- 4996.35
- Kovai Medical Centre and Hospital
- 4062
- 27.8
- 0.69
- 4271.95
- 1946.38
- 4444.75
- Thyrocare Technologies
- 646.75
- -2.3
- -0.35
- 722
- 449.95
- 3423.25
- Shalby
- 273.85
- -1.95
- -0.71
- 333.85
- 134.8
- 2938.68
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Vijaya Diagnostic Centre
- 68.34
- 12.5
- 22.14
- 21.2
- Healthcare Global Enterprises
- 168.95
- 5.86
- -7.77
- -5.21
- Kovai Medical Centre and Hospital
- 37.38
- 6.06
- 18.22
- 11.04
- Thyrocare Technologies
- 48.57
- 6.54
- 21.96
- 19.56
- Shalby
- 43.17
- 3.15
- 5.41
- 7.74
Kovai Medical Centre and Hospital Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-24
- Audited Results & Final Dividend
- 09-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 29-May-23
- Audited Results & Final Dividend
- 10-Feb-23
- Quarterly Results
- 11-Nov-22
- Quarterly Results
- 11-Aug-22
- Quarterly Results
- 27-May-22
- Audited Results
- 11-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 08-Jan-24
- 05-Dec-23
- POM
- 25-Aug-23
- 30-May-23
- AGM
- 16-Sept-21
- 03-Jun-21
- AGM
- 29-Jul-21
- 22-Jun-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 29-May-23
- 11-Aug-23
- 11-Aug-23
- 5
- 30-May-23
- 11-Aug-23
- 11-Aug-23
- 5
- 27-May-22
- -
- 25-Aug-22
- 3
- 28-May-22
- -
- 25-Aug-22
- 3
- 03-Jun-21
- -
- 02-Sept-21
- 3